Monoclonal antibodies

Animal Cell Technology: From Biopharmaceuticals to Gene Therapy

Volumn , Issue , 2008, Pages 409-433

  Tamashiro, Wirla M S C ^a   Augusto, Elisabeth F P ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Institute for Technological Research of the State of Sao Paulo   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857630393     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (59)

1. Abbas AK, Lichtman AH, Pober JS (2000), Cellular and Molecular Immunology, 4th Ed., WB Saunders, Philadelphia.
2. Bibila T, Robinson DK (1995), In pursuit of the optimal fed-batch process for monoclonal antibody production, Biotechnol. Prog. 11:1-13.
3. Bibila T, Glazomitsky K, Ranucci CS, Robinson DK, Silberklang M, Buckland BC, Aunins JG (1994), Monoclonal antibody process development using medium concentrates, Biotechnol. Prog. 10:87-96.
4. Butler M (2005), Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals, Appl. Microbiol. Biotechnol. 68:283-291.
5. Cherlet M, Marc A (2000), Stimulation of monoclonal antibody production of hybridoma cells by butyrate: evaluation of a feeding strategy and characterization of cell behavior, Cytotechnology 32:17-29.
6. Chisti Y (2000), Animal cell damage in sparged bioreactors, Trends Biotechnol. 18:420-432.
7. Chu L, Robinson DK (2001), Industrial choices for protein production by large-scale cell culture, Curr. Opin. Biotechnol. 12:180-187.
8. Cotton RG, Milstein C (1973), Fusion of two immunoglobulin-producing myeloma cells, Nature 244:42-43.
9. Dalili M, Ollis DF (1988), The influence of cyclic nucleotides on hybridoma growth and monoclonal antibody production, Biotechnol. Lett. 10:781-786.
10. De St Groth FS, Scheidegger D (1980), Production of monoclonal antibodies: strategies and tactics, J. Immunol. Methods 35:1-21.
11. Doverskog M, Ljunggren J, Ohman L, Haggstron, L (1997), Physiology of cultured animal cells, J. Biotechnol. 59:103-115.
12. Duval D, Demangel C, Jolain KM, Miossec S, Geahel I (1991), Factors controlling cell proliferation and antibody production in mouse hybridoma cells: I. Influence of the amino acid supply, Biotechnol. Bioeng. 38:561-570.
13. Emanuel PA, Dang J, Gebhardt JS, Aldrich J, Garber EAE, Kulaga H, Stopa P, Valdes JJ, Dion-Schultz A (2000), Recombinant antibodies: a new reagent for biological agent detection, Biosens. Bioelectron. 14:751-759.
14. Falkenberg FW (1998), Monoclonal antibody production: problems and solutions, Res. Immunol. 149:542-547.
15. Glassy MC, Tharakan JP, Chau PC (1988), Serum-free media in hybridoma culture and monoclonal antibody production, Biotechnol. Bioeng. 32:1015-1028.
16. Hendriksen CFM, Leeuw W (1998), Production of monoclonal antibodies by the ascites method in laboratory animals, Res. Immunol. 149:535-542.
17. Hiller GW, Clark DS, Blanch HW (1994), Transient response of hybridoma cells in continuous culture to step changes in amino acid and vitamin concentrations, Biotechnol. Bioeng. 44:303-321.
18. Horibata K, Harris AW (1977), Mouse myelomas and lymphomas in culture, Exp. Cell Res. 60:61-77.
19. Hudson PJ, Souriau C (2003), Engineered antibodies, Nat. Med. 9:129-134.
20. Huhalov A, Chester KA (2004), Engineered single chain antibody fragments for radioimmunotherapy, Q. J. Nucl. Med. Mol. Imag. 48:279-88.
21. Irving RA, Hudson PJ, Goding JW (1996), Construction, screening and expression of recombinant antibodies, In: Goding JW (Ed.), Monoclonal Antibodies: Principles and Practice, 3rd Ed., Academic Press, Manchester, pp. 424-464.
22. Jang JD, Barford JP (2000), Effect of feed rate and antibody production in the fedbatch culture of murine hybridoma cells, Cytotechnology 32:229-242.
23. Jeong YH, Wang SS (1995), Role of glutamine in hybridoma cell culture: effects on cell growth, antibody production, and cell metabolism, Enzyme and Microbial Technology 17:47-55.
24. Jo EC, Kim DI, Moon HM (1993a), Step-fortifications of nutrients in mammalian cell culture, Biotechnol. Bioeng. 42:1218-1228.
25. Jo EC, Park HJ, Kim DI, Moon HM (1993b), Repeated fed-batch culture of hybridoma cells in nutrient- fortified high-density medium, Biotechnol. Bioeng. 42:1229-1237.
26. Karpas A, Dremucheva A, Czepulkowski B H (2001), A human myeloma cell line suitable for the generation of human monoclonal antibodies, Proc. Natl Acad. Sci. U S A 98:1799-1804.
27. Köhler G (1981), The technique of hybridoma production, In: Immunological Methods, vol. II, Academic Press, pp. 285-308.
28. Köhler G, Milstein C (1975a), Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256:495-497.
29. Köhler G, Milstein C (1975b), Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion, Eur. J. Immunol. 6:511-519.
30. Köhler G, Shulman MJ (1978), Cellular and molecular restrictions of the lymphocyte fusion, Curr. Top. Microbiol. Immunol. 81:143-148.
31. Kretzmer G (2002), Industrial processes with animal cells, Appl. Microbiol. Biotechnol. 59:135-142.
32. Lin MZ, Teitell MA, Schiller GJ (2005), The evolution of antibodies into versatile tumor-targeting agents, Clin. Cancer Res. 11:129-38.
33. Little M, Kipriyanov SM, Le Gall F, Moldenhauer G (2000), Of mice and men:hybridoma and recombinant antibodies, Immunol. Today 21:364-370.
34. Littlefield JW (1964), Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants, Science 145:709-710.
35. Maki R, Traunecker A, Sakano H, Roeder W, Tonegawa S (1980), Exon shuffling generates an immunoglobulin heavy chain gene, Proc. Natl Acad. Sci. U S A 77:2138-2142.
36. Moro AM, Rodrigues MTA, Gouveia MN, Silvestri MLZ, Kalil JE, Raw I (1994), Multi-parametric analyses of hybridoma growth on glass cylinders in a packedbed bioreactor system with internal aeration. Serum-supplemented and serum-free media comparison for MAb production, J. Immunol. Methods 176:67-77.
37. NAS (1999), Monoclonal Antibody Production, National Academic Press, Washington, DC.
38. Nelson PN, Reynolds GM, Waldron EE, Ward E, Giannopoulos K, Murray PG (2000), Demystified monoclonal antibodies, J. Clin. Pathol. Mol. Pathol. 53:111-117.
39. Ozturk SS, Palsson BO (1991), Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor, Biotechnol. Prog. 7:481-494.
40. Ozturk SS, Riley MR, Palsson BO (1992), Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production, Biotechnol. Bioeng. 39:418-431.
41. Pernis B, Chiappino G, Kelus AS, Gell PGH (1965), Cellular localization of immunoglobulins with different allotypic specificities in rabbit lymphoid tissues, J. Exp. Med. 122:853-877.
42. Reddy S, Bauer KD, Miller WM (1992), Determination of antibody content in live versus dead hybridoma cells: analysis of antibody production in osmotically stressed cultures, Biotechnol. Bioeng. 40:947-964.
43. Reichert J, Pavlou A (2004), Monoclonal antibodies market, Nat. Rev. 3:383-384.
44. Roque ACA, Lowe CR, Taipa MA (2004), Antibodies and genetically engineered related molecules: production and purification, Biotechnol. Prog. 20:639-654.
45. Ryu JS, Lee GM (1999), Application of hypoosmolar medium to fed-batch culture of hybridoma cells for improvement of culture longevity, Biotechnol. Bioeng. 62:120-123.
46. Sakano H, Maki R, Kurosawa Y, Roeder W, Tonegawa S (1980), Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes, Nature 286:676-83.
47. Sauer PW, Burky JE, Wesson MC, Sternard HD, Qu L (2000), A high yielding, generic fed-batch cell culture process for production of recombinant antibodies, Biotechnol. Bioeng. 67:565-597.
48. Schneider M, Marison IW, von Stockar U (1996), The importance of ammonia in mammalian cell culture, J. Biotechnol. 46:161-185.
49. Shulman M, Wilde CD, Köhler G (1978), A better cell line for making hybridomas secreting specific antibodies, Nature 276:269-270.
50. Steinitz M, Klein JG, Koskimies S, Makel O (1977), EB virus-induced B lymphocyte cell lines producing specific antibody, Nature 269:420-422.
51. Tonegawa S, Maxamt AM, Tizardt R, Bernard O, Gilbertt W (1978), Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain, Proc. Natl Acad. Sci. U S A 75:1485-1489.
52. Vaisbourd M, Ignatovich O, Dremucheva A, Karpas A, Winter G (2001), Molecular characterization of human monoclonal antibodies derived from fusions of tonsil lymphocytes with a human myeloma cell line, Hybrid Hybridomics 20:287-92.
53. van Dijk MA, van de Winkel JGJ (2001), Human antibodies as next generation therapeutics, Curr. Opin. Chem. Biol. 5:368-374.
54. Vijayalakshmi MA (1989), Pseudobiospecific ligand affinity chromatography, Trends Biotechnol. 7:71-76.
55. Watson JD, Gilman M, Witkowski J, Zoller M (1998), Recombinant DNA, 2nd Ed., Scientific American Books, New York.
56. Wu J (1995), Mechanisms of animal cell damage associated with gas bubbles and cell protection by medium additives, J. Biotechnol. 43:81-94.
57. Wurm FM (2004), Production of recombinant protein therapeutics in cultivated mammalian cells, Nat. Biotechnol. 22:1393-1398.
58. Xie L, Wang DIC (1997), Integrated approaches to the design of media and feeding strategies for fed-batch cultures of animal cells, Trends Biotechnol. 15:109-113.
59. Xie L, Wang DIC (2006), Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies, Biotechnol. Bioeng. 95:270-284.